U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07274969) titled 'The Effect of Caffeine Therapy in Cardiovascular Stability in Preterm Neonates at Assiut University Children Hospital NICU' on Sept. 28.

Brief Summary: Preterm neonates younger than 37 weeks gestational age receiving caffeine therapy for apnea of prematurity in a NICU setting.

Study Start Date: June 30, 2026

Study Type: OBSERVATIONAL

Condition: Preterm Neonates Apnea of Prematurity

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University

Information provided by (Responsible Party): Margret Azer, Assiut University

Disclaimer: Curated by HT Syndication....